Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
genital chancroid: HIV-negative
antibiotic therapy
Chancroid usually responds well to appropriate antibiotic therapy.
The Centers for Disease Control and Prevention (CDC) recommend several antibiotic regimens, which are equally effective in most patients: azithromycin (single-dose regimen); ceftriaxone (single-dose regimen); ciprofloxacin (multiple-dose regimen); or erythromycin (multiple-dose regimen).[55]Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968 http://www.ncbi.nlm.nih.gov/pubmed/34292926?tool=bestpractice.com
Systemic fluoroquinolone antibiotics, such as ciprofloxacin, may cause serious, disabling, and potentially long-lasting or irreversible adverse events. This includes, but is not limited to: tendinopathy/tendon rupture; peripheral neuropathy; arthropathy/arthralgia; aortic aneurysm and dissection; heart valve regurgitation; dysglycemia; and central nervous system (CNS) effects including seizures, depression, psychosis, and suicidal thoughts and behavior.[74]Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804. https://pmc.ncbi.nlm.nih.gov/articles/PMC10056716 http://www.ncbi.nlm.nih.gov/pubmed/36986665?tool=bestpractice.com Prescribing restrictions apply to the use of fluoroquinolones, and these restrictions may vary between countries. In general, fluoroquinolones should be restricted for use in serious, life-threatening bacterial infections only. Some regulatory agencies may also recommend that they must only be used in situations where other antibiotics, that are commonly recommended for the infection, are inappropriate (e.g., resistance, contraindications, treatment failure, unavailability). Consult your local guidelines and drug information source for more information on suitability, contraindications, and precautions.
All sexual partners within the 10 days prior to the onset of symptoms should be traced and treated, even if they are asymptomatic, to reduce the risk of reinfection.[31]Lautenschlager S, Kemp M, Christensen JJ, et al. 2017 European guideline for the management of chancroid. Int J STD AIDS. 2017 Mar;28(4):324-9. http://www.ncbi.nlm.nih.gov/pubmed/28081686?tool=bestpractice.com [55]Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968 http://www.ncbi.nlm.nih.gov/pubmed/34292926?tool=bestpractice.com [77]McClean H, Radcliffe K, Sullivan A, et al. 2012 BASHH statement on partner notification for sexually transmissible infections. Int J STD AIDS. 2013 Apr;24(4):253-61. http://www.ncbi.nlm.nih.gov/pubmed/23970656?tool=bestpractice.com
Primary options
azithromycin: 1 g orally as a single dose
OR
ceftriaxone: 250 mg intramuscularly as a single dose
OR
ciprofloxacin: 500 mg orally twice daily for 3 days
OR
erythromycin base: 500 mg orally three times daily for 7 days
lymph node aspiration ± incision and drainage
Treatment recommended for SOME patients in selected patient group
Inguinal lymphadenitis usually does not resolve until at least 2 weeks after completion of treatment and may take much longer.
Repeated needle aspiration, with or without incision and drainage, may be required if fluctuant lymphadenitis does not resolve.[76]Schmid GP. Treatment of chancroid, 1997. Clin Infect Dis. 1999 Jan;28 Suppl 1:S14-20. https://academic.oup.com/cid/article/28/Supplement_1/S14/412218 http://www.ncbi.nlm.nih.gov/pubmed/10028106?tool=bestpractice.com
ceftriaxone or erythromycin or azithromycin
Chancroid usually responds well to appropriate antibiotic therapy.
The selection of antibiotics in a pregnant patient requires care. Ceftriaxone, erythromycin, or azithromycin are acceptable choices for therapy in pregnancy; however, macrolides should be used with caution in the first trimester as population-based cohort studies have found an increased risk of cardiovascular and digestive system malformations. Fluoroquinolones (e.g., ciprofloxacin) are not recommended in women who are pregnant or breastfeeding.[31]Lautenschlager S, Kemp M, Christensen JJ, et al. 2017 European guideline for the management of chancroid. Int J STD AIDS. 2017 Mar;28(4):324-9. http://www.ncbi.nlm.nih.gov/pubmed/28081686?tool=bestpractice.com [55]Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968 http://www.ncbi.nlm.nih.gov/pubmed/34292926?tool=bestpractice.com
All sexual partners within the 10 days prior to the onset of symptoms should be traced and treated, even if they are asymptomatic, to reduce the risk of reinfection.[31]Lautenschlager S, Kemp M, Christensen JJ, et al. 2017 European guideline for the management of chancroid. Int J STD AIDS. 2017 Mar;28(4):324-9. http://www.ncbi.nlm.nih.gov/pubmed/28081686?tool=bestpractice.com [55]Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968 http://www.ncbi.nlm.nih.gov/pubmed/34292926?tool=bestpractice.com [77]McClean H, Radcliffe K, Sullivan A, et al. 2012 BASHH statement on partner notification for sexually transmissible infections. Int J STD AIDS. 2013 Apr;24(4):253-61. http://www.ncbi.nlm.nih.gov/pubmed/23970656?tool=bestpractice.com
Primary options
ceftriaxone: 250 mg intramuscularly as a single dose
OR
erythromycin base: 500 mg orally three times daily for 7 days
OR
azithromycin: 1 g orally as a single dose
lymph node aspiration ± incision and drainage
Treatment recommended for SOME patients in selected patient group
Inguinal lymphadenitis usually does not resolve until at least 2 weeks after completion of treatment and may take much longer.
Repeated needle aspiration with or without incision and drainage may be required if fluctuant lymphadenitis does not resolve.[76]Schmid GP. Treatment of chancroid, 1997. Clin Infect Dis. 1999 Jan;28 Suppl 1:S14-20. https://academic.oup.com/cid/article/28/Supplement_1/S14/412218 http://www.ncbi.nlm.nih.gov/pubmed/10028106?tool=bestpractice.com
genital chancroid: HIV-positive
antibiotic therapy
Chancroid usually responds well to appropriate antibiotic therapy; however, patients with HIV are prone to treatment failure. Because evidence is limited with the single-dose regimens, multiple-dose regimens with ciprofloxacin or erythromycin may be preferred in patients with HIV, especially if follow-up is uncertain.[31]Lautenschlager S, Kemp M, Christensen JJ, et al. 2017 European guideline for the management of chancroid. Int J STD AIDS. 2017 Mar;28(4):324-9. http://www.ncbi.nlm.nih.gov/pubmed/28081686?tool=bestpractice.com [55]Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968 http://www.ncbi.nlm.nih.gov/pubmed/34292926?tool=bestpractice.com [72]Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999 Feb;75(1):3-17. http://sti.bmj.com/content/sextrans/75/1/3.full.pdf http://www.ncbi.nlm.nih.gov/pubmed/10448335?tool=bestpractice.com [75]Annan NT, Lewis DA. Treatment of chancroid in resource-poor countries. Expert Rev Anti Infect Ther. 2005 Apr;3(2):295-306. http://www.ncbi.nlm.nih.gov/pubmed/15918786?tool=bestpractice.com
Systemic fluoroquinolone antibiotics, such as ciprofloxacin, may cause serious, disabling, and potentially long-lasting or irreversible adverse events. This includes, but is not limited to: tendinopathy/tendon rupture; peripheral neuropathy; arthropathy/arthralgia; aortic aneurysm and dissection; heart valve regurgitation; dysglycemia; and CNS effects including seizures, depression, psychosis, and suicidal thoughts and behavior.[74]Rusu A, Munteanu AC, Arbănași EM, et al. Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile? Pharmaceutics. 2023 Mar 1;15(3):804. https://pmc.ncbi.nlm.nih.gov/articles/PMC10056716 http://www.ncbi.nlm.nih.gov/pubmed/36986665?tool=bestpractice.com Prescribing restrictions apply to the use of fluoroquinolones, and these restrictions may vary between countries. In general, fluoroquinolones should be restricted for use in serious, life-threatening bacterial infections only. Some regulatory agencies may also recommend that they must only be used in situations where other antibiotics, that are commonly recommended for the infection, are inappropriate (e.g., resistance, contraindications, treatment failure, unavailability). Consult your local guidelines and drug information source for more information on suitability, contraindications, and precautions.
All sexual partners within the 10 days prior to the onset of symptoms should be traced and treated, even if they are asymptomatic, to reduce the risk of reinfection.[31]Lautenschlager S, Kemp M, Christensen JJ, et al. 2017 European guideline for the management of chancroid. Int J STD AIDS. 2017 Mar;28(4):324-9. http://www.ncbi.nlm.nih.gov/pubmed/28081686?tool=bestpractice.com [55]Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968 http://www.ncbi.nlm.nih.gov/pubmed/34292926?tool=bestpractice.com [77]McClean H, Radcliffe K, Sullivan A, et al. 2012 BASHH statement on partner notification for sexually transmissible infections. Int J STD AIDS. 2013 Apr;24(4):253-61. http://www.ncbi.nlm.nih.gov/pubmed/23970656?tool=bestpractice.com
Primary options
ciprofloxacin: 500 mg orally twice daily for 3 days
OR
erythromycin base: 500 mg orally three times daily for 7 days
Secondary options
azithromycin: 1 g orally as a single dose
OR
ceftriaxone: 250 mg intramuscularly as a single dose
lymph node aspiration ± incision and drainage
Treatment recommended for SOME patients in selected patient group
Inguinal lymphadenitis usually does not resolve until at least 2 weeks after completion of treatment and may take much longer.
Repeated needle aspiration with or without incision and drainage may be required if fluctuant lymphadenitis does not resolve.[76]Schmid GP. Treatment of chancroid, 1997. Clin Infect Dis. 1999 Jan;28 Suppl 1:S14-20. https://academic.oup.com/cid/article/28/Supplement_1/S14/412218 http://www.ncbi.nlm.nih.gov/pubmed/10028106?tool=bestpractice.com
erythromycin or ceftriaxone or azithromycin
Chancroid usually responds well to appropriate antibiotic therapy; however, patients with HIV are prone to treatment failure. Because evidence is limited with the single-dose regimens, multiple-dose regimens may be preferred in patients with HIV, especially if follow-up is uncertain.[31]Lautenschlager S, Kemp M, Christensen JJ, et al. 2017 European guideline for the management of chancroid. Int J STD AIDS. 2017 Mar;28(4):324-9. http://www.ncbi.nlm.nih.gov/pubmed/28081686?tool=bestpractice.com [55]Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968 http://www.ncbi.nlm.nih.gov/pubmed/34292926?tool=bestpractice.com [72]Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect. 1999 Feb;75(1):3-17. http://sti.bmj.com/content/sextrans/75/1/3.full.pdf http://www.ncbi.nlm.nih.gov/pubmed/10448335?tool=bestpractice.com [75]Annan NT, Lewis DA. Treatment of chancroid in resource-poor countries. Expert Rev Anti Infect Ther. 2005 Apr;3(2):295-306. http://www.ncbi.nlm.nih.gov/pubmed/15918786?tool=bestpractice.com
Ceftriaxone, erythromycin, or azithromycin are acceptable choices for therapy in pregnancy; however, macrolides should be used with caution in the first trimester as population-based cohort studies have found an increased risk of cardiovascular and digestive system malformations. Fluoroquinolones (e.g., ciprofloxacin) are not recommended in women who are pregnant or breastfeeding.
All sexual partners within the 10 days prior to the onset of symptoms should be traced and treated, even if they are asymptomatic, to reduce the risk of reinfection.[31]Lautenschlager S, Kemp M, Christensen JJ, et al. 2017 European guideline for the management of chancroid. Int J STD AIDS. 2017 Mar;28(4):324-9. http://www.ncbi.nlm.nih.gov/pubmed/28081686?tool=bestpractice.com [55]Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968 http://www.ncbi.nlm.nih.gov/pubmed/34292926?tool=bestpractice.com [77]McClean H, Radcliffe K, Sullivan A, et al. 2012 BASHH statement on partner notification for sexually transmissible infections. Int J STD AIDS. 2013 Apr;24(4):253-61. http://www.ncbi.nlm.nih.gov/pubmed/23970656?tool=bestpractice.com
Primary options
erythromycin base: 500 mg orally three times daily for 7 days
Secondary options
ceftriaxone: 250 mg intramuscularly as a single dose
OR
azithromycin: 1 g orally as a single dose
lymph node aspiration ± incision and drainage
Treatment recommended for SOME patients in selected patient group
Inguinal lymphadenitis usually does not resolve until at least 2 weeks after completion of treatment and may take much longer.
Repeated needle aspiration with or without incision and drainage may be required if fluctuant lymphadenitis does not resolve.[76]Schmid GP. Treatment of chancroid, 1997. Clin Infect Dis. 1999 Jan;28 Suppl 1:S14-20. https://academic.oup.com/cid/article/28/Supplement_1/S14/412218 http://www.ncbi.nlm.nih.gov/pubmed/10028106?tool=bestpractice.com
no response to initial treatment
reassessment of diagnosis and treatment
If there is no clinical improvement 3-7 days after completion of treatment, the patient should be reassessed.[55]Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968 http://www.ncbi.nlm.nih.gov/pubmed/34292926?tool=bestpractice.com Consider: alternative diagnoses and/or coinfection with another pathogen; whether the patient may have been noncompliant with treatment; antimicrobial susceptibility testing to guide selection of an appropriate, alternative agent.[55]Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344968 http://www.ncbi.nlm.nih.gov/pubmed/34292926?tool=bestpractice.com
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer